ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2022 Congress

COVID and Coagulation

Theme Navigation

  • ISTH 2022 Congress
    • COVID and Coagulation
      • COVID and Coagulation, Basic Science
      • COVID and Coagulation, Clinical

Abstract Number: VPB0607

A Comparison of eNOS-based Platelet Subpopulation Ratios and Platelet VEGF Content within COVID-19

A. Asgari1, B. Ritchie2, P. Jurasz3

Abstract Number: PO0012

A frequency of anti-PF4/heparin antibodies and LA in patients with COVID-19

T. KIM1, S. Namgoong2, M. Choi2, H. Kim3, S. Jang4

Abstract Number: PB0051

A Multicenter Cohort Study of COVID-19 Associated Venous Thromboembolism in Admitted Patients Followed Longitudinally 3-Months After Discharge

C. Drury1, C. Lai2, G. Misselbrook3, A. Al Zaki2, G. Bhangu4, M. Conroy5, L. Eadie4, D. Kumar6, C. Li5, D. Manhas5, N. Singh4, J. Yuan4, A. Lee2, T. Wan7

Abstract Number: OC 13.5

A Multicenter Randomized Clinical Trial of Modulation of Host Thromboinflammatory Response in Hospitalized Patients with COVID-19: The DAWn-Antico study

M. Engelen1, J. Wauters1, J. Gunst1, C. Wouters1, C. Vandenbriele1, S. Rex1, M. Thomeer2, T. Fivez2, D. Mesotten2, D. Ruttens2, L. Heytens3, P. Verhamme4, T. Vanassche5

Abstract Number: VPB0141

A near real-time surveillance algorithm to identify in-hospital VITT cases

S. Williams, S. Sivapalaratnam, S. Vohra, P. Johnstone, A. Pentony, C. Gutteridge

Abstract Number: PB0045

A pilot, open-label, phase II clinical trial of nebulised recombinant tissue-plasminogen activator in patients with COVID-19 acute respiratory distress syndrome: the PACA trial

P. Chowdary1, B. Agarwal2, S. Bhagani3, M. Lipman4, K. Gomez5

Abstract Number: PB0054

A role for Von Willebrand Factor-ADAMTS13 axis imbalance and abnormal angiogenesis in Long COVID syndrome

H. Fogarty1, S. Ward2, L. Townsend3, E. Karampini2, S. Elliott4, M. Byrne5, C. Bergin3, J. O'Sullivan6, I. Martin-Loeches7, P. Nadarajan8, C. Bannon3, R. Preston9, A. Rehill2, C. Ni Cheallaigh3, J. O'Donnell2

Abstract Number: PB0604

Abridging Molecular System Network of COVID-19 and Thrombosis

M. Hussain1, A. Amanullah1, N. Jabeen2, B. Kantarcioglu3, F. Siddiqui3, J. Fareed3

Abstract Number: OC 33.3

Absence of Hypercoagulability after nCoV-19 Vaccination: an observational longitudinal study

C. Simion1, E. Campello2, C. Bulato1, L. Spiezia3, D. Tormene4, C. Radu1, S. Gavasso1, N. Perin1, M. Sartori3, P. Simioni5

Abstract Number: PB0600

ADAMTS13 activity and non-parallel vWF Ristocetin CoFactor activity are associated with severity of COVID-19 infection

S. MacDonald1, D. White1, S. Cox-Morton1, M. Sharp1, E. Duff1, C. Bridgeman1, T. Edwards1, C. Moore1, E. Vilar2, M. Besser1, E. Symington1, M. Robinson1, W. Thomas1

Abstract Number: PB0091

ADAMTS13 in the diagnosis of the severity of COVID-19 mortality

L. Slavík1, J. Ulehlova1, P. Bradacova2, M. Jancova3, J. Prochazkova1, A. Hlusi1

Abstract Number: VPB0611

Alteration of circulating ACE2 regulating microRNAs profiles in patients with COVID-19

Z. Wicik1, C. Eyileten1, J. Jarosz-Popek1, D. Jakubik1, A. Nowak1, M. Wolska2, A. Shahzadi3, D. Martins-Jr4, S. Simões5, J. Siller-Matula6, M. Postula1

Abstract Number: VPB0130

Alterations in the coagulation profile and mortality due to covid-19 during the first and second wave in peruvians: A retrospective cohort in a national reference center.

R. Pichardo-Rodriguez1, W. Peña-Oscuvilca2, L. cordova-Cueva3, J. DE LA CRUZ-VARGAS4, O. Ruiz-Franco2, F. Garmendia-Lorena2

Abstract Number: PB0592

Altered Fibrin Network Structure and Fibrinolysis in Intensive Care Unit Patients with COVID-19, Not Entirely Explaining the Increased Risk of Thrombosis

J. de Vries1, C. Visser1, L. Geers2, J. Slotman3, N. van Kleef4, C. Maas5, H. Bax6, J. Miedema7, E. van Gorp8, M. Goeijenbier9, J. van den Akker10, H. Endeman10, D. Rijken2, M. Kruip2, M. de Maat11

Abstract Number: VPB0612

Angiostatin and Plasminogen Levels as Risk Factors for Mortality in Hospitalized Covid-19 Patients

A. Franczak1, S. Rathwell2, W. Alemayehu2, P. Jurasz3

Abstract Number: OC 33.5

Anti-PF4 IgG levels in patients with VITT remain high at 7 months following vaccination and can still activate platelets

S. Montague1, C. Smith2, C. Lodwick3, C. Stoneley4, M. Roberts4, G. Lowe5, W. Lester4, S. Watson1, P. Nicolson6

Abstract Number: PB0596

Anti-SARS-CoV-2 vaccines do not induce a hypercoagulable state in healthy individuals

L. Garabet1, A. Eriksson2, E. Tjønnfjord3, M. Olsen3, H. Jacobsen2, C. Tøvik Jørgensen2, Å. Mathisen2, M. Mowinckel4, M. Ahlen5, I. Sørvoll5, P. Sandset6, W. Ghanima7

Abstract Number: PB0076

Antiphospholipid antibodies in patients with acute ischaemic stroke during the COVID-19 pandemic

P. Mittal1, M. Efthymiou2, R. Simister3, Z. Sayar4, A. Chandratheva3, D. Werring3, H. Cohen5

Abstract Number: PB0042

Antithrombotics and antihistamine use correlated with increased COVID-19 severity. Antithrombotics and antihistamine use correlated with increased COVID-19 severity.

M. Khan1, V. Chan2, C. Maynard2, I. Asekomhe2, M. Brennan1

Abstract Number: PB0080

Are drug-drug interactions clinically relevant?. Use of edoxaban concomitant to ritonavir in COVID-19 hospitalized patients with atrial fibrillation

P. Olivera1, D. Campoy1, C. Velásquez-Escandón2, T. Canals3, K. Flores4, E. Johansson4, C. Hernandez5, O. Benitez5

  • 1
  • 2
  • 3
  • …
  • 9
  • Next Page »

« View all themes from the ISTH 2022 Congress

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley